# Oropharynx (OPX) Salivary Biomarker Study

> **NCT05093400** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 100 (actual)

## Conditions studied

- Healthy

## Interventions

- **OTHER:** no intervention

## Key facts

- **NCT ID:** NCT05093400
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-17
- **Primary completion:** 2023-05-02
- **Final completion:** 2023-05-05
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05093400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05093400, "Oropharynx (OPX) Salivary Biomarker Study". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT05093400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*